Valerie Ohlendorf
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 23, 2025
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection.Lisa Sandmann, Valerie Ohlendorf, Alena Ehrenbauer
|Oct 19, 2024
Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients.Valerie Ohlendorf, Maximilian Wübbolding, Christoph Höner Zu Siederdissen
|Feb 24, 2023
Reply to the letter "Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B".Valerie Ohlendorf, Benjamin Maasoumy
|Sep 24, 2022
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients.Valerie Ohlendorf, Maximilian Wübbolding, Paul Gineste
|May 18, 2021
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R).Valerie Ohlendorf, Arne Schäfer, Stefan Christensen
Pageof 1
